動物用抗生物質・抗菌薬市場：製品、送達方法、形態、動物タイプ別-2024-2030年世界予測

動物用抗生物質・抗菌薬市場規模は、2023年に6億3,551万米ドルと推定され、2024年には6億6,723万米ドルに達し、CAGR 5.25%で2030年には9億984万米ドルに達すると予測されています。

動物用抗生物質・抗菌薬には、動物の細菌感染を治療・予防し、健康と福祉を促進するために使用される物質が含まれます。食生活の変化に伴う動物性タンパク質に対する世界の需要の高まりが市場を牽引しています。畜産の激化と家畜の病気予防の重要性に対する意識の高まりが抗生物質の使用量増加に寄与しています。さらに、獣医学的ヘルスケアにおける進歩や、家畜全体の生産性を向上させることに重点を置くことが、動物衛生分野における抗生物質・抗菌剤の需要をさらに促進しています。抗生物質の過剰使用は耐性菌の発生につながるため、抗菌薬耐性（AMR）に対する懸念が大きな課題となっています。規制による制限や、より持続可能な農法を目指す動きが、畜産における特定の抗生物質の使用抑制に寄与しています。プロバイオティクスやフィトジェニックのような、従来の抗生物質に代わる抗生物質の開発動向の高まりは、動物衛生分野における技術革新の機会を提示しています。さらに、ワクチンやバイオセキュリティの実践といった予防対策への注目の高まりは、動物用抗生物質・抗菌薬市場の持続的成長の機会を提供しています。

製品病気の予防と治療のための抗生物質へのニーズの高まり

抗生物質は動物ヘルスケアにおいて重要な役割を担っており、病気の予防、治療、成長促進など様々な目的で使用されています。動物医療分野で最も一般的に使用されている抗生物質は、テトラサイクリン系、ペニシリン系、スルホンアミド系、マクロライド系です。抗菌剤は、動物の微生物を破壊または増殖を阻害する薬剤です。抗生物質、抗真菌剤、抗原虫薬、抗ウイルス剤などが含まれます。その用途は酪農、家禽、養豚、水産養殖など様々な分野に及び、動物の健康と福祉を確保し、感染症の影響を緩和します。

投与方法：非侵襲的な処置であるため、経口投与への傾斜が高まっています。

注射は合理的な投与方法であり、血流に直接吸収されるため、動物医療におけるドラッグデリバリーの一般的かつ効果的な方法です。この投与方法は消化器官を迂回するため、医療作用の発現が早くなることが多いです。ペニシリン、アモキシシリンなどの抗生物質や、リン酸オセルタミビルなどの抗ウイルス剤は、標的を絞って即効性を高めるため、注射で投与されることが多いです。動物用の抗生物質や抗菌薬の経口投与は、最も非侵襲的で便利な投与方法です。その主な利点は投与が容易なことであり、特に小規模農家や最低限の医療技術しか持たないペットの飼い主に適しています。

形態重篤な細菌感染症の動物個体に対する抗菌薬溶液の使用増加

粉末や錠剤は、動物用抗生物質や抗菌剤の一般的な固形剤です。最適な安定性、費用対効果、正確な投与が可能なことから支持を集めています。飲料水や飼料に混ぜて経口投与されるため、動物病院での使用に便利です。抗菌液は通常、経口投与、乳房内投与、非経口投与などの関連経路で提供されます。幅広い細菌感染症に対応し、即効性と迅速な吸収を提供します。溶液は投与量を容易に変更できるため、様々な動物のニーズに基づいた個別の治療計画を容易に立てることができます。

動物の種類コンパニオンアニマルの間で拡大する、細菌感染症を管理するための抗生物質と抗菌薬の必要性

猫を含むコンパニオンアニマルは、様々な細菌感染症にかかりやすく、尿路感染症や猫ひっかき病など、様々な形で症状が現れます。アモキシシリンやドキシサイクリンなどの抗生物質は、その広域抗菌特性から一般的に使用されています。獣医師は、犬の細菌感染に対してエンロフロキサシンやアモキシシリンなどの抗生物質を処方することが多いです。治療対象となる一般的な病気には、皮膚感染症、尿路感染症、呼吸器疾患などがあります。馬医療で使用される一般的な抗生物質には、ペニシリン、ゲンタマイシン、オキシテトラサイクリンなどがあり、肺炎、皮膚感染症、再生性貧血などの病気を治療します。微生物耐性を防ぐためには、正しい用量を投与することが極めて重要です。抗生物質は牛の健康管理に不可欠です。テトラサイクリン系抗生物質やスルホンアミド系抗生物質は、牛の呼吸器疾患や乳房炎の予防によく使用されます。抗生物質の誤用は、抗菌剤耐性や食物連鎖汚染の原因となります。リンコマイシンやクロルテトラサイクリンを含む抗生物質は、豚赤痢や肺炎などの疾病予防のために、豚の生産現場で頻繁に使用されています。食の安全を確保するためには、抗生物質の責任ある使用を維持することが不可欠です。エンロフロキサシン、アモキシシリン、ドキシサイクリンは、鳥コレラ、伝染性気管支炎、コクシジウム症などの病気の治療と予防のため、養鶏で一般的に使用されています。

地域別インサイト

南北アメリカでは、集約的な畜産が盛んで、動物福祉が重視されつつあることが、動物用抗生物質・抗菌薬市場を牽引しています。動物由来製品に対する需要の高まりと、家畜の疾病予防に対する意識の高まりが、この地域における抗生物質の普及に寄与しています。高度な獣医ヘルスケアインフラと厳しい規制がさらに状況を形成しており、北米と南米諸国が積極的に市場情勢の拡大に貢献しています。アジア太平洋地域では、動物用抗生物質・抗菌薬市場は、特に中国やインドを含む国々での動物性タンパク質需要の増加により、大幅な成長を遂げています。畜産業の拡大と動物の健康と生産性の向上への関心の高まりが、この地域での抗生物質の採用を後押ししています。EMEA地域では、特に欧州諸国において、家畜の抗生物質使用に関する厳しい規制が動物用抗生物質・抗菌薬市場に影響を与えています。持続可能な農法が重視され、抗菌剤耐性に対する懸念が高まっていることも、市場力学の形成に寄与しています。さらに、中東とアフリカでは、都市化の進展と食生活の変化により、畜産活動が拡大しています。EMEA地域は、責任ある効果的な動物用抗生物質・抗菌薬の使用という世界の方向性の舵取りにおいて極めて重要な役割を果たしています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは動物用抗生物質・抗菌薬市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、動物用抗生物質・抗菌薬市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.動物用抗生物質・抗菌薬市場の市場規模および予測は？

2.動物用抗生物質・抗菌薬市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.動物用抗生物質・抗菌薬市場の技術動向と規制枠組みは？

4.動物用抗生物質・抗菌薬市場における主要ベンダーの市場シェアは？

5.動物用抗生物質・抗菌薬市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 畜産物の需要増加とペニシリン系抗生物質の需要増加
    • 動物疾病の発生への対策における政府の関与の強化
    • 動物の病気の治療薬開発への巨額の資本投資増加
  • 抑制要因
    • 抗生物質に対する耐性に関する懸念厳格な規制承認
  • 機会
    • 先端研究開発施設と新薬開発活動の加速
    • 新しい抗菌剤の持続可能性への注目の高まり
  • 課題
    • 代替品の入手可能性
• 市場セグメンテーション分析
  • 製品：病気の予防と治療のための抗生物質の需要の高まり
  • 投与方法：非侵襲的な処置であるため、経口投与への傾向が高まっている
  • 形態：重度の細菌感染症に罹患した個々の動物の治療に抗菌溶液の使用が増加
  • 動物の種類：細菌感染を管理するために、ペット動物における抗生物質と抗菌剤の需要が拡大している
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 動物用抗生物質・抗菌薬市場：製品別

• 抗生物質
• 抗菌性

第7章 動物用抗生物質・抗菌薬市場配送方法別

• 注射
• オーラル

第8章 動物用抗生物質・抗菌薬市場：形態別

• 粉末と錠剤
• ソリューション

第9章 動物用抗生物質・抗菌薬市場動物の種類別

• コンパニオンアニマル
• 食用動物

第10章 南北アメリカの動物用抗生物質・抗菌薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の動物用抗生物質・抗菌薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの動物用抗生物質・抗菌薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • ゾエティスは米国でリブレラ（ベディンベトマブ注射剤）の商業発売により犬におけるイノベーションを実証
  • ヒューベファーマ、FDA承認の唯一のトリプルサルファ剤を米国市場に復帰
  • エランコとギンコ・バイオワークスがマイクロバイオーム技術を活用した新しい動物医療会社バイオムエディットを設立
• 戦略分析と提言

第14章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET RESEARCH PROCESS
• FIGURE 2. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET DYNAMICS
• FIGURE 7. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 18. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 24. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANTIMICROBIAL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANTIMICROBIAL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY INJECTIONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY INJECTIONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY POWDERS & TABLETS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY POWDERS & TABLETS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SOLUTIONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CATS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CATS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DOGS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DOGS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY HORSES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY HORSES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CATTLE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CATTLE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PIGS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PIGS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY POULTRY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY POULTRY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 49. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 50. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 51. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2023 (USD MILLION)
• TABLE 52. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2024-2030 (USD MILLION)
• TABLE 53. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 54. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 55. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2023 (USD MILLION)
• TABLE 56. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2024-2030 (USD MILLION)
• TABLE 57. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2023 (USD MILLION)
• TABLE 58. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2024-2030 (USD MILLION)
• TABLE 59. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2023 (USD MILLION)
• TABLE 60. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2024-2030 (USD MILLION)
• TABLE 61. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 62. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 63. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 64. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 65. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2023 (USD MILLION)
• TABLE 66. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2024-2030 (USD MILLION)
• TABLE 67. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 68. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 69. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2023 (USD MILLION)
• TABLE 70. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2024-2030 (USD MILLION)
• TABLE 71. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2023 (USD MILLION)
• TABLE 72. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2024-2030 (USD MILLION)
• TABLE 73. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2023 (USD MILLION)
• TABLE 74. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2024-2030 (USD MILLION)
• TABLE 75. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 76. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 77. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2023 (USD MILLION)
• TABLE 78. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2024-2030 (USD MILLION)
• TABLE 79. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 80. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 81. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2023 (USD MILLION)
• TABLE 82. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2024-2030 (USD MILLION)
• TABLE 83. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2023 (USD MILLION)
• TABLE 84. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2024-2030 (USD MILLION)
• TABLE 85. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2023 (USD MILLION)
• TABLE 86. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2024-2030 (USD MILLION)
• TABLE 87. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 88. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 89. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2023 (USD MILLION)
• TABLE 90. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2024-2030 (USD MILLION)
• TABLE 91. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 92. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 93. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2023 (USD MILLION)
• TABLE 94. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2024-2030 (USD MILLION)
• TABLE 95. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2023 (USD MILLION)
• TABLE 96. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2024-2030 (USD MILLION)
• TABLE 97. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2023 (USD MILLION)
• TABLE 98. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2024-2030 (USD MILLION)
• TABLE 99. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 100. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 101. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2023 (USD MILLION)
• TABLE 102. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2024-2030 (USD MILLION)
• TABLE 103. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 104. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 105. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2023 (USD MILLION)
• TABLE 106. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2024-2030 (USD MILLION)
• TABLE 107. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2023 (USD MILLION)
• TABLE 108. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2024-2030 (USD MILLION)
• TABLE 109. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2023 (USD MILLION)
• TABLE 110. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2024-2030 (USD MILLION)
• TABLE 111. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 112. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 113. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2023 (USD MILLION)
• TABLE 114. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2024-2030 (USD MILLION)
• TABLE 115. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 116. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 117. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2023 (USD MILLION)
• TABLE 118. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2024-2030 (USD MILLION)
• TABLE 119. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2023 (USD MILLION)
• TABLE 120. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2024-2030 (USD MILLION)
• TABLE 121. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2023 (USD MILLION)
• TABLE 122. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2024-2030 (USD MILLION)
• TABLE 123. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 124. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 125. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 126. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 127. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2023 (USD MILLION)
• TABLE 128. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2024-2030 (USD MILLION)
• TABLE 129. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 130. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 131. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2023 (USD MILLION)
• TABLE 132. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2024-2030 (USD MILLION)
• TABLE 133. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2023 (USD MILLION)
• TABLE 134. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2024-2030 (USD MILLION)
• TABLE 135. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2023 (USD MILLION)
• TABLE 136. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2024-2030 (USD MILLION)
• TABLE 137. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 138. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 139. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 140. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 141. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2023 (USD MILLION)
• TABLE 142. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2024-2030 (USD MILLION)
• TABLE 143. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 144. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 145. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2023 (USD MILLION)
• TABLE 146. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2024-2030 (USD MILLION)
• TABLE 147. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2023 (USD MILLION)
• TABLE 148. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2024-2030 (USD MILLION)
• TABLE 149. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2023 (USD MILLION)
• TABLE 150. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2024-2030 (USD MILLION)
• TABLE 151. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 152. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 153. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2023 (USD MILLION)
• TABLE 154. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2024-2030 (USD MILLION)
• TABLE 155. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 156. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 157. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2023 (USD MILLION)
• TABLE 158. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2024-2030 (USD MILLION)
• TABLE 159. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2023 (USD MILLION)
• TABLE 160. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2024-2030 (USD MILLION)
• TABLE 161. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2023 (USD MILLION)
• TABLE 162. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2024-2030 (USD MILLION)
• TABLE 163. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 164. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 165. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2023 (USD MILLION)
• TABLE 166. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2024-2030 (USD MILLION)
• TABLE 167. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 168. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 169. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2023 (USD MILLION)
• TABLE 170. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2024-2030 (USD MILLION)
• TABLE 171. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2023 (USD MILLION)
• TABLE 172. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2024-2030 (USD MILLION)
• TABLE 173. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2023 (USD MILLION)
• TABLE 174. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2024-2030 (USD MILLION)
• TABLE 175. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 176. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 177. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2023 (USD MILLION)
• TABLE 178. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2024-2030 (USD MILLION)
• TABLE 179. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 180. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 181. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2023 (USD MILLION)
• TABLE 182. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2024-2030 (USD MILLION)
• TABLE 183. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2023 (USD MILLION)
• TABLE 184. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2024-2030 (USD MILLION)
• TABLE 185. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2023 (USD MILLION)
• TABLE 186. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2024-2030 (USD MILLION)
• TABLE 187. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 188. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 189. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2023 (USD MILLION)
• TABLE 190. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2024-2030 (USD MILLION)
• TABLE 191. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 192. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 193. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2023 (USD MILLION)
• TABLE 194. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2024-2030 (USD MILLION)
• TABLE 195. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2023 (USD MILLION)
• TABLE 196. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2024-2030 (USD MILLION)
• TABLE 197. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2023 (USD MILLION)
• TABLE 198. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2024-2030 (USD MILLION)
• TABLE 199. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 200. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 201. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2023 (USD MILLION)
• TABLE 202. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2024-2030 (USD MILLION)
• TABLE 203. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 204. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 205. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2023 (USD MILLION)
• TABLE 206. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2024-2030 (USD MILLION)
• TABLE 207. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2023 (USD MILLION)
• TABLE 208. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2024-2030 (USD MILLION)
• TABLE 209. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2023 (USD MILLION)
• TABLE 210. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2024-2030 (USD MILLION)
• TABLE 211. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 212. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 213. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2023 (USD MILLION)
• TABLE 214. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2024-2030 (USD MILLION)
• TABLE 215. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 216. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 217. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2023 (USD MILLION)
• TABLE 218. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2024-2030 (USD MILLION)
• TABLE 219. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2023 (USD MILLION)
• TABLE 220. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2024-2030 (USD MILLION)
• TABLE 221. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2023 (USD MILLION)
• TABLE 222. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2024-2030 (USD MILLION)
• TABLE 223. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 224. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 225. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2023 (USD MILLION)
• TABLE 226. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2024-2030 (USD MILLION)
• TABLE 227. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 228. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 229. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2023 (USD MILLION)
• TABLE 230. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2024-2030 (USD MILLION)
• TABLE 231. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2023 (USD MILLION)
• TABLE 232. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2024-2030 (USD MILLION)
• TABLE 233. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2023 (USD MILLION)
• TABLE 234. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2024-2030 (USD MILLION)
• TABLE 235. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 236. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 237. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2023 (USD MILLION)
• TABLE 238. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2024-2030 (USD MILLION)
• TABLE 239. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 240. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 241. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2023 (USD MILLION)
• TABLE 242. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2024-2030 (USD MILLION)
• TABLE 243. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2023 (USD MILLION)
• TABLE 244. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2024-2030 (USD MILLION)
• TABLE 245. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2023 (USD MILLION)
• TABLE 246. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2024-2030 (USD MILLION)
• TABLE 247. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 248. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 249. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2023 (USD MILLION)
• TABLE 250. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2024-2030 (USD MILLION)
• TABLE 251. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 252. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 253. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2023 (USD MILLION)
• TABLE 254. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2024-2030 (USD MILLION)
• TABLE 255. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2023 (USD MILLION)
• TABLE 256. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2024-2030 (USD MILLION)
• TABLE 257. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2023 (USD MILLION)
• TABLE 258. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2024-2030 (USD MILLION)
• TABLE 259. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 260. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 261. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2023 (USD MILLION)
• TABLE 262. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2024-2030 (USD MILLION)
• TABLE 263. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 264. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 265. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2023 (USD MILLION)
• TABLE 266. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2024-2030 (USD MILLION)
• TABLE 267. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2023 (USD MILLION)
• TABLE 268. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2024-2030 (USD MILLION)
• TABLE 269. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2023 (USD MILLION)
• TABLE 270. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2024-2030 (USD MILLION)
• TABLE 271. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 272. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 273. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2023 (USD MILLION)
• TABLE 274. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2024-2030 (USD MILLION)
• TABLE 275. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 276. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 277. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2023 (USD MILLION)
• TABLE 278. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2024-2030 (USD MILLION)
• TABLE 279. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2023 (USD MILLION)
• TABLE 280. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2024-2030 (USD MILLION)
• TABLE 281. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2023 (USD MILLION)
• TABLE 282. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2024-2030 (USD MILLION)
• TABLE 283. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 284. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 285. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2023 (USD MILLION)
• TABLE 286. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2024-2030 (USD MILLION)
• TABLE 287. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 288. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 289. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2023 (USD MILLION)
• TABLE 290. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2024-2030 (USD MILLION)
• TABLE 291. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2023 (USD MILLION)
• TABLE 292. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2024-2030 (USD MILLION)
• TABLE 293. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2023 (USD MILLION)
• TABLE 294. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS &

[190 Pages Report] The Animal Antibiotics & Antimicrobials Market size was estimated at USD 635.51 million in 2023 and expected to reach USD 667.23 million in 2024, at a CAGR 5.25% to reach USD 909.84 million by 2030.

Animal antibiotics & antimicrobials include substances used to treat and prevent bacterial infections in animals, promoting their health and welfare. The rising global demand for animal protein, driven by changing dietary patterns, is driving the market. The intensification of animal farming and increased awareness of the importance of preventing diseases in livestock contribute to the growing usage of antibiotics. Additionally, advancements in veterinary healthcare and a focus on improving overall animal productivity further propel the demand for antibiotics & antimicrobials in the animal health sector. Concerns over antimicrobial resistance (AMR) pose a significant challenge, as the overuse of antibiotics can lead to the development of resistant strains of bacteria. Regulatory restrictions and a push towards more sustainable farming practices contribute to the restraint on the use of certain antibiotics in animal agriculture. The growing trend toward the development of alternatives to traditional antibiotics, such as probiotics and phytogenics, presents an opportunity for innovation in the animal health sector. Furthermore, increased focus on preventive measures, such as vaccines and biosecurity practices, offers opportunities for sustainable growth in the animal antibiotics & antimicrobials market.

Product: Growing need for antibiotics for disease prevention and treatment

Antibiotics present a significant component in animal healthcare, deployed for a myriad of purposes, including disease prevention, treatment, and growth promotion. The most commonly used antibiotics in the animal health sector are tetracyclines, penicillins, sulfonamides, and macrolides. Antimicrobials are agents that destroy or inhibit the growth of microorganisms in animals. These include antibiotics, antifungals, antiprotozoals, and antivirals. Their application spans various segments, including dairy, poultry, swine, and aquaculture, to ensure the health and welfare of animals and to mitigate the impacts of infectious diseases.

Mode of Delivery: Rising inclination towards oral administration as it's a non-invasive procedure

Injection is a common and effective method of drug delivery in veterinary medicine due to its streamlined administration and direct absorption into the bloodstream. This mode of delivery bypasses the digestive barriers and often results in a faster onset of medical action. Antibiotics such as penicillin, amoxicillin, and antivirals such as oseltamivir phosphate are often administered via injections for targeted, immediate relief. Oral delivery of antibiotics & antimicrobials for animals is the most non-invasive and convenient mode of delivery. Its main advantage lies in its ease of administration, particularly suitable for small scale farmers or pet owners with minimal medical proficiency.

Form: Increasing usage of antimicrobial solutions for treating individual animals with severe bacterial infections

Powders & tablets are common solid dosage forms for animal antibiotics and antimicrobials. They have gained traction due to their optimal stability, cost-effectiveness, and the potential for precision dosing. They are administered orally in drinking water or feed, making them a convenient option for veterinary use. Antimicrobial solutions are typically provided through allied routes, including oral, intramammary, or parenteral administration. They cater to a broad spectrum of bacterial infections and provide instant relief and rapid absorption. Solutions can be easily modified in terms of dosage, facilitating personalized treatment plans based on varying animal needs.

Type of Animal: Expanding need for antibiotics & antimicrobials among companion animals to manage bacterial infections

Companion animals including cats are prone to various bacterial infections, which manifest in different forms of diseases such as urinary tract infection and cat-scratch disease. Antibiotics such as amoxicillin and doxycycline are commonly used for their broad-spectrum antimicrobial properties. Veterinarians often prescribe antibiotics including enrofloxacin and amoxicillin for bacterial infections in dogs. Some common illnesses treated include skin infections, urinary tract infections, and respiratory diseases. Common antibiotics used in equine medicine include penicillin, gentamicin, and oxytetracycline to treat ailments such as pneumonia, skin infections, and regenerative anemia. It's crucial to administer the correct dosage to prevent microbial resistance. Antibiotics are vital for cattle health management. Tetracyclines and sulfonamides are frequently used for the prevention of bovine respiratory disease and mastitis. Misuse of antibiotics can lead to antimicrobial resistance and food-chain contamination. Frequent use of antibiotics in swine production, including lincomycin and chlortetracycline, is common for the prevention of diseases such as swine dysentery and pneumonia. It's essential to maintain the responsible use of antibiotics to ensure food safety. Enrofloxacin, amoxicillin, and doxycycline are typically used in poultry farming for the treatment and prevention of diseases such as avian cholera, infectious bronchitis and coccidiosis.

Regional Insights

In the Americas, the market for animal antibiotics & antimicrobials is driven by the significant presence of intensive animal farming practices and a growing emphasis on animal welfare. The rising demand for animal-derived products, coupled with increased awareness of disease prevention in livestock, contributes to the widespread use of antibiotics in the region. Advanced veterinary healthcare infrastructure and stringent regulations further shape the landscape, with North and South American countries actively contributing to the expansion of the animal antibiotics & antimicrobials market. In the Asia-Pacific region, the animal antibiotics & antimicrobials market experiences substantial growth due to the increasing demand for animal protein, particularly in countries including China and India. The expansion of the livestock industry, coupled with a rising focus on improving animal health and productivity, drives the adoption of antibiotics in the region. Within the EMEA region, the market for animal antibiotics & antimicrobials is influenced by stringent regulations on antibiotic use in livestock, particularly in European countries. The emphasis on sustainable farming practices and heightened concerns about antimicrobial resistance contribute to shaping the market dynamics. Additionally, the Middle East and Africa witness growth in animal farming activities, driven by increasing urbanization and dietary changes. The EMEA region plays a pivotal role in steering the global direction of responsible and effective use of animal antibiotics & antimicrobials.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Animal Antibiotics & Antimicrobials Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Animal Antibiotics & Antimicrobials Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Animal Antibiotics & Antimicrobials Market, highlighting leading vendors and their innovative profiles. These include American Regent Inc., Ayurvet, Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Chanelle Pharma, Dechra Pharmaceuticals PLC, Eco Animal Health Group PLC, Elanco Animal Health Incorporated, Eli Lilly and Company, Endovac Animal Health, LLC, Hester Biosciences Limited, Hipra Laboratories, S.A., Inovet Group, Neogen Corporation, Norbrook Laboratories Ltd., Novartis AG, Phibro Animal Health Corporation, Sanofi-Aventis Groupe S.A., Tianjin Ringpu Biotechnology Co., Ltd., Vetoquinol S.A., Virbac S.A., Zoetis, Inc., and Zydus Pharmaceuticals, Inc..

Market Segmentation & Coverage

This research report categorizes the Animal Antibiotics & Antimicrobials Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Antibiotics
  • Antimicrobial

• Mode of Delivery
  • Injections
  • Oral

• Form
  • Powders & Tablets
  • Solutions

• Type of Animal
  • Companion Animals
    • Cats
    • Dogs
    • Horses

• Food-Producing Animals
  • Cattle
  • Pigs
  • Poultry
  • Sheep & Goats
• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Animal Antibiotics & Antimicrobials Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Animal Antibiotics & Antimicrobials Market?

3. What are the technology trends and regulatory frameworks in the Animal Antibiotics & Antimicrobials Market?

4. What is the market share of the leading vendors in the Animal Antibiotics & Antimicrobials Market?

5. Which modes and strategic moves are suitable for entering the Animal Antibiotics & Antimicrobials Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising demand for livestock products and strong demand for penicillin based antibiotics
    • 5.1.1.2. Increasing government involvement in countering animal diseases outbreaks
    • 5.1.1.3. Growing huge capital investment for the development of drugs for animal diseases
  • 5.1.2. Restraints
    • 5.1.2.1. Concerns regarding resistance to antibiotic stringent regulatory approvals
  • 5.1.3. Opportunities
    • 5.1.3.1. Accelerating advanced research and development facilities, and new drug development activities
    • 5.1.3.2. Growing focus towards sustainability of new antimicrobials
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of substitutes
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Growing need for antibiotics for disease prevention and treatment
  • 5.2.2. Mode of Delivery: Rising inclination towards oral administration as it's a non-invasive procedure
  • 5.2.3. Form: Increasing usage of antimicrobial solutions for treating individual animals with severe bacterial infections
  • 5.2.4. Type of Animal: Expanding need for antibiotics & antimicrobials among companion animals to manage bacterial infections
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Animal Antibiotics & Antimicrobials Market, by Product

• 6.1. Introduction
• 6.2. Antibiotics
• 6.3. Antimicrobial

7. Animal Antibiotics & Antimicrobials Market, by Mode of Delivery

• 7.1. Introduction
• 7.2. Injections
• 7.3. Oral

8. Animal Antibiotics & Antimicrobials Market, by Form

• 8.1. Introduction
• 8.2. Powders & Tablets
• 8.3. Solutions

9. Animal Antibiotics & Antimicrobials Market, by Type of Animal

• 9.1. Introduction
• 9.2. Companion Animals
• 9.3. Food-Producing Animals

10. Americas Animal Antibiotics & Antimicrobials Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Animal Antibiotics & Antimicrobials Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Animal Antibiotics & Antimicrobials Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Zoetis Demonstrates Canine Innovation with Commercial Launch of Librela (bedinvetmab injection) in the U.S.
  • 13.3.2. Huvepharma Returns The Only FDA-Approved Triple-Sulfa Medication To US Market
  • 13.3.3. Elanco and Ginkgo Bioworks Launch BiomEdit, a New Animal Health Company Leveraging Microbiome Technology
• 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

• 14.1. Key Company Profiles
• 14.2. Key Product Portfolio